Search results for " Lower"

showing 10 items of 378 documents

Adaptive neural state-feedback stabilizing controller for nonlinear systems with mismatched uncertainty

2014

In this paper, an adaptive neural network (NN) state-feedback controller for a class of nonlinear systems with mismatched uncertainties is presented. By using a radial basis (RBF) neural network, a bound of unknown nonlinear functions is approximated so that no information about the upper bound of mismatched uncertainties is required. The state-feedback is based on Lyapunov stability theory, and it is shown that the asymptotic convergence of the closed-loop system to zero is achieved while maintaining bounded states at the same time. The presented methods are more general than the previous approaches, handling systems with no restriction on the dimension of the system and the number of inpu…

Lyapunov stabilityNonlinear systemEngineeringArtificial neural networkControl theorybusiness.industryAdaptive systemBounded functionConvergence (routing)businessUpper and lower boundsProceeding of the 11th World Congress on Intelligent Control and Automation
researchProduct

Gastropods from upper Pliensbachian–Toarcian (Lower Jurassic) sediments of Causses Basin, southern France and their recovery after the early Toarcian…

2015

AbstractA gastropod fauna has been studied from upper Pliensbachian – upper Toarcian deposits of two sections of the Causses Basin (southern France) in order to investigate the mode of recovery after the early Toarcian anoxic event. The fauna consists of 15 species, one of which is new (Bathrotomaria kronzwilmesorumsp. nov.). Their stratigraphical distribution shows two peaks of diversity – in the Bifrons Zone (Bifrons Subzone) and in the Aalensis Zone (Mactra Subzone) – which reflect brief times during which the oxygen content and bottom consistency favoured the settlement of a relatively diversified fauna. In the Variabilis–Pseudoradiosa zones, gastropods are only represented by two speci…

MactraSystematicsbiologyearly Toarcian anoxic eventFaunaGastropodaSpecies diversityGeologyStructural basinbiology.organism_classificationAnoxic watersGastropoda; Lower Jurassic; PalaeobiogeographyPaleontologyPalaeobiogeographyTaxonLower JurassicGastropodaFrancesystematicsGeology[ SDU.STU.PG ] Sciences of the Universe [physics]/Earth Sciences/Paleontology
researchProduct

Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell …

2005

We have attempted to identify those subgroups of patients most likely to develop lymph node metastases from squamous cell carcinoma of the lower lip (LLSSC). A total of 97 subjects, who did not undergo elective neck dissection, were recruited into the 60-month disease-free survival study. After univariate analysis, tumour size, histological grading, maximal thickness, perineural invasion and immunoreactivity to cyclin D1 and p27Kip1 proteins proved to be significant factors. Tests of the effect of interaction between p27Kip1 LI and tumour thickness yielded that the impact of tumour thickness on the risk of lymph node metastases was modified by the percentage of p27Kip1 positive cells. Subse…

MaleCancer ResearchPathologymedicine.medical_specialtyp27Kip1medicine.medical_treatmentPerineural invasionCell Cycle ProteinsSettore MED/08 - Anatomia PatologicaMetastasisLymph node metastasiCyclin D1Squamous cell carcinomaBiomarkers TumorCarcinomaHumansMedicineCyclin D1Lymph nodeTumour thickness.AgedAged 80 and overbusiness.industryTumor Suppressor ProteinsNeck dissectionMiddle AgedPrognosismedicine.diseaseImmunohistochemistryLymph node metastasis; Squamous cell carcinoma; Lower lip; Cyclin D1; p27Kip1; Tumour thickness.medicine.anatomical_structureOncologyEpidermoid carcinomaLymphatic MetastasisLip NeoplasmsLower lipCarcinoma Squamous CellRegression AnalysisImmunohistochemistryFemaleOral SurgerybusinessCyclin-Dependent Kinase Inhibitor p27Oral Oncology
researchProduct

Early-life weight gain, prematurity, and asthma development.

2014

Early childhood asthma is a clinical syndrome, the development and clinical manifestations of which result from a complex interplay among airway anatomy, physiology, and inflammation. Although multiple phenotypes of early childhood wheezing and asthma have been described, the mechanisms that promote and differentiate these phenotypes remain poorly understood. Over the past decade, substantial understanding has emerged as to the early-life factors that influence childhood asthma development. One area of great interest has been the relationships between patterns of fetal and infant growth, subsequent wheezing, and asthma. Although several studies strongly suggest that intrauterine growth patt…

MalePediatricsmedicine.medical_specialtyAllergyBirth weightImmunologyBMI Body mass indexWeight GainAsthma and Lower Airway Diseasechildrencohort studiesWheezemedicineImmunology and AllergyBirth WeightHumansEarly childhoodlow birth weightSDS Standard deviation scoresAsthmaFetusinfant growthISAAC International Study on Asthma and Allergy in Childhoodbusiness.industrywheezingGestational ageasthmamedicine.diseasepOR Pooled odds ratioPremature BirthFemaleepidemiologymedicine.symptombusinessBody mass indexWeight gainOR Odds ratioThe Journal of allergy and clinical immunology
researchProduct

Noradrenaline depleting and blood pressure lowering activity of threo-corbadrine

1968

Abstract Threo-corbadrine caused a long-lasting depletion of noradrenaline in the heart and in mesenteric vessels and lowered the blood pressure of normal and renal hypertensive rats. It is suggested that threo-cobadrine decreases vascular tone by acting peripherally as a substitute adrenergic transmitter.

MalePharmacologymedicine.medical_specialtyHypertension RenalChromatography PaperChemistryInjections SubcutaneousAdrenergicBlood PressureMethylationRatsVascular tonePlethysmographyNorepinephrineEndocrinologyBlood pressureEthanolaminesLevonordefrinInternal medicinemedicineAnimalsPlethysmographFluorometryBlood pressure loweringEuropean Journal of Pharmacology
researchProduct

Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow‐up study

2017

Essentials Late sequelae of isolated superficial vein thrombosis (iSVT) have rarely been investigated. We studied 411 consecutive outpatients with acute iSVT with a median follow-up of three years. Male sex and cancer are risk factors for future deep vein thrombosis or pulmonary embolism. Patients without cancer appear to be at a negligible risk for death. SUMMARY Background Studies of long-term thromboembolic complications and death following acute isolated superficial vein thrombosis (iSVT) of the lower extremities are scarce. Objectives To investigate the course of iSVT in the setting of an observational multicenter study. Methods We collected longitudinal data of 411 consecutive outpati…

MaleTime FactorsSuperficial vein thrombosisDeep veinKaplan-Meier Estimate030204 cardiovascular system & hematology0302 clinical medicineRecurrenceRisk FactorsInterquartile rangecohort study; death; major bleeding; superficial vein thrombosis; venous thromboembolism; Adult; Aged; Anticoagulants; Cause of Death; Female; Hemorrhage; Humans; Incidence; Italy; Kaplan-Meier Estimate; Longitudinal Studies; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Neoplasms; Odds Ratio; Proportional Hazards Models; Pulmonary Embolism; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Venous ThrombosisCause of DeathNeoplasmssuperficial vein thrombosiOdds RatioLongitudinal StudiesCause of deathVenous ThrombosisIncidenceAnticoagulantHematologyMiddle AgedThrombosisPulmonary embolismVenous thrombosisTreatment Outcomemedicine.anatomical_structureItalyLower Extremity030220 oncology & carcinogenesisFemaleAdultmedicine.medical_specialtymedicine.drug_classvenous thromboembolismHemorrhage03 medical and health sciencesSex FactorsdeathInternal medicinesuperficial vein thrombosiscohort studymedicineHumansAgedProportional Hazards ModelsRetrospective Studiesbusiness.industryAnticoagulantsmedicine.diseaseSurgerymajor bleedingMultivariate AnalysisPulmonary Embolismbusinesscohort study; death; major bleeding; superficial vein thrombosis; venous thromboembolism; HematologyJournal of Thrombosis and Haemostasis
researchProduct

An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals

2020

Aims To improve attainment of LDL-cholesterol (LDL-c) targets, an expert group proposed an algorithm for lipid-lowering therapy during hospitalization for acute coronary syndrome and during follow-up. We aimed to assess adherence to this algorithm, and evaluate its impact on LDL-c levels and on attainment of therapeutic LDL-c targets in a population of post-acute coronary syndrome patients. Methods and results Prospective, observational study including patients admitted for acute coronary syndrome between February 2017 and September 2018. Patients admitted without statins or ezetimibe were considered ‘naïve’. Baseline LDL-c was admission LDL-c in naïve patients, and for those taking lipid-…

Malemedicine.medical_specialtyAcute coronary syndromeStatinmedicine.drug_classLow density lipoprotein cholesterol030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineLipid-lowering therapy03 medical and health sciences0302 clinical medicineEzetimibeInternal medicinemedicineHumansProspective Studies030212 general & internal medicineAcute Coronary SyndromeAgedbusiness.industryAnticholesteremic AgentsCholesterol LDLGeneral MedicineEzetimibePrognosismedicine.diseaseExpert groupHospitalizationCardiologyPatient ComplianceLDL Cholesterol LipoproteinsFemalelipids (amino acids peptides and proteins)Lipid loweringCardiology and Cardiovascular MedicinebusinessAlgorithmsBiomarkersFollow-Up Studiesmedicine.drugEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

Gracilis free muscle transfer for morpho-functional reconstruction of the lower lip.

2007

Background. Large full-thickness defects of the lower lip need free tissue transfer. The free forearm flap is the more widespread technique for free flap lower lip reconstruction, but it results in a static lip. The authors describe a technique of morphodynamic sensate reconstruction of the lower lip with a free gracilis flap and a musculomucosal flap. Methods. Three patients underwent reconstruction with an innervated free muscular gracilis flap, an innervated musculo-mucosal flap for the vermillion (2 cases), and a full-thickness skin graft. Results. No significant complications were observed. Static function and vermillion sensitivity were immediately restored. The skin color match was e…

Malemedicine.medical_specialtyLower lipFree flaptotal lower lip reconstruction • free innervated gracilis flap • lower lip carcinoma • sensate lower lip reconstruction • dynamic lower lip reconstructionSurgical FlapsLip NeoplasmLip reconstructionmedicineHumansGracilis muscleSurgical FlapsMuscle SkeletalAgedbusiness.industryAnatomyLipSurgeryFunctional reconstructionstomatognathic diseasesOtorhinolaryngologyLip NeoplasmsCarcinoma Squamous CellMuscle transferNeoplasm Recurrence LocalbusinessHeadneck
researchProduct

Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder

2017

Introduction: Lower urinary tract symptoms (LUTS) are frequent in motor neuron disease (MND) patients, but clinical factors related to them are unknown. We describe differences in LUTS among MND phenotypes and their relationship with other clinical characteristics, including prognosis. Methods: For this study, we collected clinical data of a previously published cohort of patients diagnosed with classical amyotrophic lateral sclerosis (cALS), progressive muscular atrophy (PMA) or primary lateral sclerosis (PLS) with and without LUTS. Familial history was recorded and the C9ORF72 expansion was analysed in the entire cohort Patients were followed-up for survival until August 2016. Results: Fi…

Malemedicine.medical_specialtyNeurogenic bladder030232 urology & nephrologyDiseaseMuscular Atrophy Spinal03 medical and health sciencesSex Factors0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsC9orf72Primary lateral sclerosisInternal medicinemedicineHumansLower urinary tract symptomsMotor neuron diseaseMotor Neuron DiseaseUrinary Bladder NeurogenicFamily historyAmyotrophic lateral sclerosisAgedPrimary Lateral SclerosisC9orf72 Proteinbusiness.industryAmyotrophic Lateral SclerosisMiddle AgedProgressive muscular atrophyPrognosismedicine.diseaseAmyotrophic lateral sclerosisSurvival AnalysisSurgeryUrodynamicsCross-Sectional StudiesPhenotypeNeurologyProgressive muscular atrophyAmyotrophic lateral sclerosis Lower urinary tract symptoms Motor neuron disease Neurogenic bladder Primary lateral sclerosis Progressive muscular atrophy UrodynamicsMultivariate AnalysisCohortFemaleNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm,…

2013

Summary Background Patients with homozygous familial hypercholesterolaemia respond inadequately to existing drugs. We aimed to assess the efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in adults with this disease. Methods We did a single-arm, open-label, phase 3 study of lomitapide for treatment of patients with homozygous familial hypercholesterolemia. Current lipid lowering therapy was maintained from 6 weeks before baseline through to at least week 26. Lomitapide dose was escalated on the basis of safety and tolerability from 5 mg to a maximum of 60 mg a day. The primary endpoint was mean percent change in levels of LDL cholesterol from baseline …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaMipomersenPhases of clinical researchSocio-culturaleFamilial hypercholesterolemialdl-apheresismtp inhibitorBenzimidazoleMicrosomal triglyceride transfer proteinHyperlipoproteinemia Type IIchemistry.chemical_compoundlipid lowering therapyInternal medicineClinical endpointMedicinelomitapidebiologybusiness.industryCholesterolMedicine (all)Homozygotelomitapide; ldl-apheresis; lipid lowering therapy; homozygous familial hypercholesterolemia; mtp inhibitorGeneral MedicineCholesterol LDLhomozygous familial hypercholesterolemiamedicine.diseaseLomitapideEndocrinologyTolerabilitychemistrybiology.proteinFemalebusinessCarrier ProteinHuman
researchProduct